Your browser doesn't support javascript.
loading
Inhibition of glioblastoma progression by Urolithin A in vitro and in vivo by regulating Sirt1-FOXO1 axis via ERK/AKT signaling pathways.
Liu, Cui-Lan; Zhao, Di; Li, Jian-Jun; Liu, Song; An, Jia-Jia; Wang, Dan; Hu, Feng-Ai; Qiu, Chang-Yun; Cui, Ming-Hu.
Afiliación
  • Liu CL; Institute for Metabolic and Neuropsychiatric Disorders, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Zhao D; Department of Psychology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Li JJ; Institute for Metabolic and Neuropsychiatric Disorders, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Liu S; Department of Psychology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • An JJ; Emergency Department, First People's Hospital of Jinan, Jinan, Shandong, China.
  • Wang D; Thyroid and Breast Surgery Department, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Hu FA; Department of Clinical Laboratory, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Qiu CY; Institute for Metabolic and Neuropsychiatric Disorders, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Cui MH; Department of Psychology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Neoplasma ; 69(1): 80-94, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34818027
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies Idioma: En Revista: Neoplasma Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies Idioma: En Revista: Neoplasma Año: 2022 Tipo del documento: Article